How Is The Market Feeling About Biomarin Pharmaceutical?
Portfolio Pulse from Benzinga Insights
Biomarin Pharmaceutical's short interest has decreased by 12.26%, with 5.28 million shares sold short, representing 2.79% of its float. This is lower than its peers' average short interest of 5.61%. The decrease in short interest may indicate a more bullish sentiment towards the stock.
October 15, 2024 | 5:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Biomarin Pharmaceutical's short interest has decreased by 12.26%, indicating a potential shift towards a more bullish market sentiment. The current short interest is 2.79% of the float, which is lower than the peer average of 5.61%.
The decrease in short interest suggests that fewer investors are betting against Biomarin, which could indicate a more positive outlook on the stock. Additionally, the short interest is lower than the peer average, further supporting a potentially bullish sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100